Physician profile
Thomas A Mayer
NPI 1013937150
$48,929.97
in general payments reported to CMS, 2019-2025
41 companies · $3,292 in 2025
The $3,292 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $8,964 · 2021: $3,368 · 2022: $3,786 · 2023: $4,652 · 2024: $4,230 · 2025: $3,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,173.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15,431.02 | 2019-2025 | Xarelto, Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $13,378.32 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Novo Nordisk INC | $3,060.25 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $2,803.31 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $2,610.35 | 2019-2025 | |
| Boston Scientific Corporation | $1,653.18 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Comet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,465.25 | 2019-2025 | Jardiance |
| Medtronic, INC. | $1,181.34 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $912.76 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $866.78 | 2022-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $858.46 | 2019-2025 | Impella |
| Pfizer INC. | $844.01 | 2019-2025 | |
| Abbott Laboratories | $819.50 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Coroflow |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $466.49 | 2019-2022 | |
| Heartflow, INC. | $328.51 | 2022-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $209.88 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $207.35 | 2022 | |
| Impulse Dynamics (USA) INC. | $175.94 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $172.57 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $162.28 | 2019 | |
| Zoll Circulation INC | $150.00 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Actelion Pharmaceuticals US, INC. | $138.87 | 2023-2025 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $134.96 | 2019 | |
| Opsens INC. | $132.00 | 2022 | |
| Janssen Scientific Affairs, LLC | $102.62 | 2022 | |
| Merck Sharp & Dohme LLC | $102.01 | 2023-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $78.36 | 2025 | |
| Alnylam Pharmaceuticals INC. | $76.11 | 2024-2025 | Onpattro |
| Bridgebio Pharma, INC. | $73.50 | 2025 | Attruby |
| Shockwave Medical, INC | $65.07 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $35.44 | 2019-2025 | Manta |
| Lilly USA, LLC | $34.89 | 2024 | Zepbound, Jardiance |
| Elutia, INC. | $27.33 | 2022 | |
| Davol INC. | $25.84 | 2025 | Progel Applicator Spray Tips |
| Esperion Therapeutics, INC. | $24.70 | 2022 | |
| Inari Medical, INC. | $23.62 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Imperative Care, INC | $22.94 | 2024 | Symphony Catheter |
| Lexicon Pharmaceuticals, INC. | $22.46 | 2024 | |
| Scpharmaceuticals INC. | $21.17 | 2024 | |
| Cordis US Corp. | $15.90 | 2025 | Mynx Control |
| Acadia Pharmaceuticals INC | $14.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.